LIR Life Sciences Corp. (CSE:SKNY)

LIR Life Sciences Statistics

Total Valuation

CSE:SKNY has a market cap or net worth of CAD 29.37 million. The enterprise value is 29.40 million.

Market Cap	29.37M
Enterprise Value	29.40M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

CSE:SKNY has 18.95 million shares outstanding.

Current Share Class	18.95M
Shares Outstanding	18.95M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+37,899.24%
Owned by Insiders (%)	10.61%
Owned by Institutions (%)	n/a
Float	16.94M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	-100.74
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-71.29
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.04

Current Ratio	0.04
Quick Ratio	0.04
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2,903.90

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	141.43%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	65.82
Average Volume (20 Days)	86,564

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	-10,000
Operating Income	-412,354
Pretax Income	-412,496
Net Income	-412,496
EBITDA	n/a
EBIT	-412,354
Earnings Per Share (EPS)	-0.04

Balance Sheet

The company has 2,612 in cash and 35,000 in debt, giving a net cash position of -32,388 or -0.00 per share.

Cash & Cash Equivalents	2,612
Total Debt	35,000
Net Cash	-32,388
Net Cash Per Share	-0.00
Equity (Book Value)	-291,568
Book Value Per Share	-0.02
Working Capital	-395,532

Cash Flow

Operating Cash Flow	-212,643
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CSE:SKNY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-1.40%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 7, 2025. It was a reverse split with a ratio of 0.6666667.

Last Split Date	Nov 7, 2025
Split Type	Reverse
Split Ratio	0.6666667

Scores

Altman Z-Score	n/a
Piotroski F-Score	1